Vanda Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VANDA PHARMS INC, and when can generic versions of VANDA PHARMS INC drugs launch?
VANDA PHARMS INC has three approved drugs.
There are thirty-six US patents protecting VANDA PHARMS INC drugs.
There are two hundred and forty-three patent family members on VANDA PHARMS INC drugs in twenty-four countries.
Summary for Vanda Pharms Inc
International Patents: | 243 |
US Patents: | 36 |
Tradenames: | 3 |
Ingredients: | 2 |
NDAs: | 3 |
Drugs and US Patents for Vanda Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-006 | May 6, 2009 | RX | Yes | No | 8,652,776 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-007 | May 6, 2009 | RX | Yes | No | 9,074,254 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-007 | May 6, 2009 | RX | Yes | No | 9,138,432 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | AB | RX | Yes | Yes | 10,610,511 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-005 | May 6, 2009 | RX | Yes | No | 9,074,256 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | AB | RX | Yes | Yes | 11,566,011 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vanda Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-004 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | 5,856,529 | ⤷ Try a Trial |
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-007 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-001 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
Vanda Pharms Inc | HETLIOZ LQ | tasimelteon | SUSPENSION;ORAL | 214517-001 | Dec 1, 2020 | 5,856,529 | ⤷ Try a Trial |
Vanda Pharms Inc | FANAPT | iloperidone | TABLET;ORAL | 022192-002 | May 6, 2009 | RE39198 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VANDA PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2018-01-31 |
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2018-01-31 |
➤ Subscribe | Tablets | 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, & 12 mg | ➤ Subscribe | 2013-05-06 |
International Patents for Vanda Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 6108633 | ⤷ Try a Trial |
South Korea | 20190006598 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2015108728 | ⤷ Try a Trial |
European Patent Office | 2134873 | ⤷ Try a Trial |
Japan | 7119261 | ⤷ Try a Trial |
South Korea | 20200022543 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.